Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 155.11
+3.71 (2.45%)
Mar 10, 2026, 3:10 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 201.04 billion as of March 10, 2026. Its market cap has decreased by -17.99% in one year.
Market Cap
201.04B
Enterprise Value
242.11B
Revenue
88.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
155.11
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 201.04B, a decrease of -11.33%. That is a compound annual growth rate of -3.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 201.04B | -12.08% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 379.08B |
| Ajanta Pharma | 373.66B |
| Gland Pharma | 274.98B |
| Emcure Pharmaceuticals | 268.42B |
| Wockhardt | 211.17B |
| Eris Lifesciences | 188.49B |
| NATCO Pharma | 182.64B |
| Alembic Pharmaceuticals | 139.26B |